Aptus Pharma Ltd.
Fundamentals
- Market cap
- ₹403 cr
- P/E
- 87.29×
- ROE
- 44.50%
- Debt / equity
- 1.49
- 52-week range
- 32.32 — 238.80
Company snapshot
Aptus Pharma Ltd.
Pharmaceuticals
₹403 cr
P/E 87.29×
Latest quarter · Mar 2026
Sales₹32 cr
Net profit₹3 cr
Op. margin+14.0%
EPS₹1.67
Strength & growth
Debt / equity1.49×
Current ratio1.63×
The timeline — 2 notes on Aptus Pharma Ltd.
June 2026
- 12 Jun 26 · 5:47 PM IST Lead Lead · Micro cap
Aptus Pharma board approves ₹51 cr fund raise for expansion
The nano-cap pharma plans to raise ₹35 cr via preferential equity, ₹10 cr debt, and ₹6 cr internal accruals. The preferential allotment is subject to approvals with pricing and allottees yet to be decided.
- 09 Jun 26 · 6:34 PM IST Brief Brief · Micro cap
Aptus Pharma's board meets next week to figure out how to raise money
The nano-cap is looking at both equity and debt. No terms are set.